Publication | Closed Access

Rimonabant, a cannabinoid CB1 receptor antagonist, attenuates mechanical allodynia and counteracts oxidative stress and nerve growth factor deficit in diabetic mice

Cannabis UseMetabolic SyndromeMechanical AllodyniaCounteracts Oxidative StressFunctional SelectivityMedicineDiabetesPhysiologyDiabetic MiceDiabetes MellitusPharmacologyCannabinoid PharmacologyCannabinoidsOxidative StressHealth Sciences